Future perspective: precision medicine to improve treatment results in the settings of allogenic stem cell transplantation for acute myelogenous leukemia

Reikvam, Håkon; Johansen, Silje; Koenecke, Christian

doi:10.1080/23808993.2021.1897464

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AML is a highly heterogeneous disease, with regard to morphology, cytogenetic, molecular genetics, and epigenetic abnormalities 2 . Based on molecular genetics, new targeted therapies have been suggested, although the disease heterogeneity makes such targeted therapies challenging 3,5 .…”

Section: Introductionmentioning

confidence: 99%

Future perspective: metabolism as a therapeutic target in acute myeloid leukemia – from Warburg to precision medicine

Hatfield

Grønningsæter

Reikvam

2021

Current Medical Research and Opinion

Self Cite

View full text Add to dashboard Cite

Acute myeloid leukemia (AML) is a highly malignant blood cancer disease, with dismal prognosis.The theory that cancer cells utilize metabolism to their growth advantage was postulated almost hundred years ago. However, only recently have been able to take advantage of this Achilles heel of malignant cell growth. Current observations suggest a crucial role for various metabolic pathways in AML, and special in leukemia stem cells (LSC), believed to be responsible for re-initiation of the leukemic clone, and hence relapse of this devastating disease. In the present article we discuss the features for metabolism in AML based on recent research, and special emphasizing the potential of pharmacological inhibiting metabolism as new treatment approaches.

show abstract

Section: Introductionmentioning

confidence: 99%